Abbott Laboratories (ABTCL.SN)

100,220.00 -7,980.00 (-7.38%) At close: 10:27AM CLT

Abbott Laboratories

100 Abbott Park Road
Abbott Park
North Chicago, IL 60064-6400
United States
224 667 6100
https://www.abbott.com

Sector(s): 
Industry: 
Full-time employees: 114,000

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Robert B. Ford	Chairman of the Board, President & CEO	4.73M	6.64M	1974
Mr. Philip P. Boudreau	CFO & Senior VP of Finance	1.14M	N/A	1973
Mr. Hubert L. Allen	Executive VP, General Counsel & Secretary	2M	N/A	1966
Mr. Robert E. Funck Jr.	Executive Vice President of Finance	2.18M	N/A	1961
Mr. Daniel Gesua Sive Salvadori	Executive VP and Group President of Established Pharmaceuticals & Nutritional Products	1.76M	N/A	1979
Ms. Lisa D. Earnhardt	Executive VP & Group President of Medical Devices	1.73M	N/A	1970
Ms. Sabina Ewing	Senior VP of Business & Technology Services and Chief Information Officer	N/A	N/A	1974
Erica L. Battaglia	VP and Chief Ethics & Compliance Officer	N/A	N/A	N/A
Ms. Melissa Brotz	Vice President of Public Affairs & Corporate Marketing	N/A	N/A	N/A
Mr. Christopher J. Scoggins	Senior Vice President of Commercial Operations, Marketing & Diabetes Care	N/A	N/A	1970

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CLP.

Description

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Corporate governance

Abbott Laboratories’s ISS governance QualityScore as of 1 June 2024 is 7. The pillar scores are Audit: 9; Board: 7; Shareholder rights: 2; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.